Rallybio (RLYB) Current Leases (2022 - 2026)
Rallybio (RLYB) posted Current Leases of $99000.0 for Q1 2026, up 5.32% sequentially from $94000.0 in Q4 2025, and down 14.66% YoY from $116000.0 in Q1 2025.
Rallybio (RLYB) Current Leases (2022 - 2026) Analysis & Trends
Rallybio has reported Current Leases for 5 years, with the latest figure at $99000.0 in Q1 2026.
- Quarterly Current Leases fell 14.66% year-over-year to $99000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99000.0 (down 14.66% YoY) and the FY2025 annual result came in at $94000.0, down 38.96% from the prior year.
- Current Leases advanced to $99000.0 in Q1 2026 per RLYB's latest filing, from $94000.0 in the prior quarter.
- Over five years, Current Leases peaked at $230000.0 in Q3 2024 and troughed at $58000.0 in Q2 2025.
- A 5-year average of $163529.4 and a median of $165000.0 in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2025: Current Leases surged 42.0% in 2023, then tumbled 74.34% in 2025.
- Over 5 years, Current Leases stood at $181000.0 in 2022, then rose by 20.99% to $219000.0 in 2023, then declined by 29.68% to $154000.0 in 2024, then tumbled by 38.96% to $94000.0 in 2025, then climbed by 5.32% to $99000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $99000.0, $94000.0, and $90000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Rallybio | 94.32 Mn | 94.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99,000.00 |
| Dec 31, 2025 | 94,000.00 |
| Sep 30, 2025 | 90,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Mar 31, 2025 | 116,000.00 |
| Dec 31, 2024 | 154,000.00 |
| Sep 30, 2024 | 230,000.00 |
| Jun 30, 2024 | 226,000.00 |
| Mar 31, 2024 | 223,000.00 |
| Dec 31, 2023 | 219,000.00 |
| Sep 30, 2023 | 217,000.00 |
| Jun 30, 2023 | 213,000.00 |
| Mar 31, 2023 | 197,000.00 |
| Dec 31, 2022 | 181,000.00 |
| Sep 30, 2022 | 165,000.00 |
| Jun 30, 2022 | 150,000.00 |
| Mar 31, 2022 | 148,000.00 |